Keyphrases
Systemic Inflammation
100%
Lipopolysaccharide
88%
Systemic Inflammatory Response
61%
Type 2 Diabetes Mellitus (T2DM)
60%
Blood Pressure Lowering
52%
DNA Binding
52%
Adaptive Response
52%
Skeletal muscle
52%
General Practice
52%
Dynamic Cerebral Autoregulation
52%
Blood Pressure Monitoring
52%
Nuclear factor-B
52%
Noradrenaline
52%
Kinase Phosphorylation
52%
Lactobacillus Acidophilus NCFM
52%
AMP-activated Protein Kinase Phosphorylation
52%
Insulin Sensitivity
52%
Human Subjects
52%
Parallel Trials
52%
C-Jun N-terminal Kinase
52%
Normal Glucose Tolerance
47%
Type 2 Diabetic Patients
39%
Mean Arterial Pressure
35%
Probiotic Bacteria
30%
Glucose Uptake
26%
Trial Registration
22%
Quantitative PCR
20%
Escherichia Coli Lipopolysaccharide
20%
Steady State
17%
Cardiovascular Risk Profile
17%
24-hour Ambulatory Blood Pressure
17%
Blood Pressure
17%
Nighttime
17%
Treatment Course
15%
Placebo
15%
Neuroscience
Lipopolysaccharide
96%
DNA B
52%
Cerebral Autoregulation
52%
DNA Binding
52%
Adaptive Response
52%
Binding Affinity
52%
Norepinephrine
52%
Kinase
52%
Amino Terminal Sequence
52%
Nuclear Factor
52%
AMP-activated Protein Kinase
52%
Erythropoietin
52%
Skeletal Muscle
52%
Alternative Complement Pathway C3 C5 Convertase
52%
Blood Plasma
28%
Glucose Transport
26%
Messenger RNA
26%
Medicine and Dentistry
Alternative Complement Pathway C3 C5 Convertase
52%
DNA B
52%
Amino Terminal Sequence
52%
Hypoxia
52%
Binding Affinity
52%
DNA Binding
52%
Skeletal Muscle
52%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
52%
Phosphotransferase
52%
Nuclear Factor
52%
Maturity Onset Diabetes of the Young
52%
Lipopolysaccharide
52%
Erythropoietin
52%
Patient with Type 2 Diabetes
39%
Glucose Tolerance
39%
Messenger RNA
26%
Glucose Uptake
26%
Muscle Biopsy
26%
